Perrigo Company Plc
Could not find a ticker for this position, may be a filing error
A maker of over-the-counter self-care products, Perrigo supplies store-brand medicines to retailers and also sells its own brands like Opill®, Mederma®, Compeed®, and Solpadeine® across North America and Europe. The company traces back to 1887, when Michigan general-store owner Luther Perrigo began packaging medicines and household goods for other country stores — and pioneered the private-label idea by printing each store's own name on the labels. The company still bears his name today.
Granted 68.6K
Granted 8.3K · Bought 7.5K
Granted 47.6K
Granted 18.0K
Granted 8.3K
Granted 7.3K
Granted 10.7K
Granted 7.3K
Granted 7.3K
Granted 17.9K
Granted 10.4K
Granted 10.6K
Granted 6.7K · Bought 1.0K
Granted 7.0K · Bought 1.3K
Granted 7.3K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Lockwood-Taylor PatrickFormer CEO and director · 8 transactions | +43.5% | 123.2K | 68.6K | — | — |
| Parker Geoffrey M.Director · 5 transactions | +2.8% | 122.8K | 8.3K | 7.5K | — |
| Bezerra Eduardo GuaritaEVP & Chief Financial Officer · 10 transactions | +73% | 84.7K | 47.6K | — | — |
| Willis RobertEVP & CHRO · 10 transactions | +24.9% | 52.4K | 18.0K | — | — |
| Alford Bradley ADirector · 4 transactions | +10.5% | 45.5K | 8.3K | — | — |
| O'Connor DonalDirector · 2 transactions | +7% | 39.1K | 7.3K | — | — |
| Ashford Orlando DDirector · 2 transactions | +25% | 27.7K | 10.7K | — | — |
| Manzone AlbertDirector · 2 transactions | +30.3% | 16.4K | 7.3K | — | — |
| Brown Julia MDirector · 2 transactions | +19.9% | 15.3K | 7.3K | — | — |
| Khoury RobertoEVP and President of CSCI · 6 transactions | +151.5% | 13.1K | 17.9K | — | — |
| Samuelson JonasDirector · 4 transactions | — | 8.9K | 10.4K | — | — |
| Ball DavidEVP & CBDO · 4 transactions | — | 7.8K | 10.6K | — | — |
| Atkinson CharlesEVP, General Counsel & Sec. · 3 transactions | — | 7.7K | 6.7K | 1.0K | — |
| Lennox AbigailEVP and CSO · 5 transactions | — | 6.6K | 7.0K | 1.3K | — |
| Egan Kevin FrancisDirector · 2 transactions | — | 3.8K | 7.3K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: +9.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.